Testing effectiveness (Phase 2)Study completedNCT00193271
What this trial is testing
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
Who this might be right for
Prostate Cancer
SCRI Development Innovations, LLC 30